MARKET

ELOX

ELOX

ELOXX PHARMACEUT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.990
-0.070
-1.72%
After Hours: 3.990 0 0.00% 16:00 01/28 EST
OPEN
4.100
PREV CLOSE
4.060
HIGH
4.280
LOW
3.950
VOLUME
140.77K
TURNOVER
--
52 WEEK HIGH
14.74
52 WEEK LOW
2.870
MARKET CAP
159.61M
P/E (TTM)
-2.7519
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ELOX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ELOX News

  • Eloxx Pharma Offers Update On Progress Of Phase 2 Programs For ELX-02, ERSG Pipeline: Sees ELX-02 Fully Enrolled In Q1'20, Topline Results In 1H'20
  • Benzinga.01/14 19:32
  • Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase™
  • GlobeNewswire.01/14 19:30
  • Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus
  • Benzinga.12/29/2019 23:38
  • Will Eloxx Continue to Surge Higher?
  • Zacks.12/27/2019 11:38

More

Industry

Biotechnology & Medical Research
+0.97%
Pharmaceuticals & Medical Research
+0.58%

Hot Stocks

Name
Price
%Change

About ELOX

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing ribonucleic acid (RNA)-modulating drug candidates, which are designed to be eukaryotic ribosomal selective glycosides (ERSG). It is developing its drug candidates for treating rare and ultra-rare premature stop codon diseases. ELX-02 is its lead investigational drug product candidate. ELX-02 is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. Its preclinical candidate pool consists of a library of novel ERSG drug candidates identified based on read-through potential and cytoplasmic ribosomal selectivity.
More

Webull offers Eloxx Pharmaceuticals Inc (ELOX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.